Insulet Corp. Stock
Price
Target price
€142.40
€142.40
1.770%
2.5
1.770%
€305.21
13.07.26 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
There is an upward development for Insulet Corp. compared to yesterday, with an increase of €2.50 (1.770%).
With 60 Buy predictions and 1 Sell predictions Insulet Corp. is one of the favorites of our community.
Based on the current price of 142.4 € the target price of 305 € shows a potential of 114.19% for Insulet Corp. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insulet Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insulet Corp. in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | 1.770% | 1.969% | 10.004% | -42.465% | -41.687% | -44.047% | -37.626% |
| CONMED Corp. | 12.050% | 12.258% | 16.779% | -23.348% | -0.571% | -70.756% | -69.739% |
| Penumbra Inc | 0.360% | -0.432% | 0.655% | 36.323% | 3.829% | -2.606% | 22.389% |
| Glaukos Corp | - | -1.481% | 22.018% | 48.603% | 37.824% | 112.800% | 116.260% |
Comments
Insulet (PODD) was given a new $210.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Royal Bank Of Canada from $280.00 to $245.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Stifel Nicolaus from $250.00 to $225.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
News
Is Insulet (PODD) the Future of Diabetes Management?
Explore the exciting world of Insulet (NASDAQ: PODD) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market
